| Stage | RDNW | % of rev | VRSN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $297M | 100.00% | $443M | 100.00% | VRSN ×1.49 |
| Gross profit | $85M | 28.57% | $393M | 88.76% | VRSN +60.2pp |
| Operating income | $18M | 6.03% | $297M | 66.93% | VRSN +60.9pp |
| Pre-tax income | $7M | 2.22% | $280M | 63.12% | VRSN +60.9pp |
| Net income | $7M | 2.19% | $213M | 47.99% | VRSN +45.8pp |
| Stage | RDNW | VRSN | Gap · A − B |
|---|---|---|---|
| Revenue | $297M100.00% | $443M100.00% | VRSN ×1.49 |
| Gross profit | 28.57%$85M | 88.76%$393M | VRSN +60.2pp |
| Operating income | 6.03%$18M | 66.93%$297M | VRSN +60.9pp |
| Pre-tax income | 2.22%$7M | 63.12%$280M | VRSN +60.9pp |
| Net income |
| 2.19%$7M |
| 47.99%$213M |
| VRSN +45.8pp |
No disclosed counterparties: VRSN.
None